A multisite, international phase 2 trial evaluating the investigational drug garetosmab has shown that it reduced soft-tissue flare-ups significantly and prevented new areas of abnormal bone formation in patients with fibrodysplasia ossificans progressiva (FOP).
Alvin C. Powers, MD, Joe C. Davis Professor of Biologic Science and professor of Medicine, Molecular Physiology and Biophysics, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center (VDC), director of the Vanderbilt Diabetes Research and Training Center (DRTC), and chief of the Vanderbilt Division of Diabetes, Endocrinology and Metabolism at Vanderbilt University Medical Center.
Sahar Takkouche, MD, assistant professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism and the director of the Vanderbilt Weight Loss Center in Wilson County, has been named to the role of associate chief medical officer (ACMO) for Wilson and Sumner County regions.
Griffin Rodgers, MD, director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, described the urgency of the nation’s diabetes epidemic July 26 during a symposium of the NIDDK Medical Student Research Program in Diabetes and Obesity hosted by Vanderbilt University.
“This study will greatly expand our knowledge about the relationship between COVID-19 and diabetes and will also provide us novel information about what factors influence the early course of diabetes in children and adults with Type 1 or Type 2 diabetes,” said principal investigator and project leader Russell Rothman, MD, MPP.
Chase Hendrickson, MD, MPH, assistant professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism, has been named executive medical director of the Medicine Patient Care Center (PCC).
Diane Saunders, PhD, research assistant professor in the Division of Diabetes, Endocrinology & Metabolism in the Department of Medicine, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes (nPOD) at its recent 2023 annual meeting.
Individuals with Type 1 diabetes have a smaller pancreas than people without diabetes. This is surprising because the pancreatic islets and their insulin-producing beta cells account for just a small fraction of the pancreas, so the loss of beta cells in Type 1 diabetes would not be expected to reduce pancreas size.
In 2017, Vanderbilt University Medical Center was selected to be one of four U.S. medical centers in a Strategically Focused Research Network (SFRN) on Obesity funded by a four-year, $15 million award from the American Heart Association to study obesity and train future obesity-focused investigators.
The 2023 Vanderbilt University School of Medicine Faculty Awards for Excellence in Teaching, Extraordinary Performance of Clinical Service, and Outstanding Contributions to Research were presented May 19 during the annual spring faculty meeting.
